Related Experiment Video
Updated: May 10, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
The studies of chlorogenic Acid antitumor mechanism by gene chip detection: the immune pathway gene expression
Tian Yi Kang1, Hua Rong Yang, Jie Zhang
1West China School of Pharmacy, Sichuan University, Chengdu 610041, Sichuan Province, China.
Abstract:
Persistently increasing incident of cancer in human beings has served to emphasize the importance of studies on mechanism of antitumor substances. Chlorogenic acid (CA), extracted from folium cortex eucommiae, has been confirmed to have lots of biological activities encompassing inhibition of tumor. However, the anticancer mechanism of CA remains unclear. Here, we have utilized a whole mouse genome oligo microarray (4∗44K) to analyze gene expression level of female BALB/c mice (implanted with EMT-6 sarcoma cells) after treatment with low, medium, and high-dose CA (5 mg/kg, 10 mg/kg, and 20 mg/kg), docetaxel, interferon, and normal saline separately at 6 time points (3rd, 6th, 9th, 12th, 15th, and 18th days after administration). Differentially expressed genes screened out by time-series analysis, GO analysis, and pathway analysis, and four immune-related genes were selected for further confirmation using RT-qPCR. The results demonstrated that CA is able to change gene expression and that the responsive genes (CaN, NFATC2, NFATC2ip, and NFATC3) involved in immune pathways had been significantly upregulated by CA. Expression of immune factors such as IL-2R and IFN- γ can be improved by CA to promote activation and proliferation of T cells, macrophages, and NK cells, thus enhancing their surveillance and killing abilities, further suppressing the growth rate of tumor cells.
Insights
Chlorogenic acid (CA) enhances antitumor immunity by upregulating immune-related genes, promoting T cell, macrophage, and NK cell activity to suppress tumor growth.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- Cancer incidence necessitates research into antitumor substance mechanisms.
- Chlorogenic acid (CA) exhibits antitumor properties, but its anticancer mechanism is not fully understood.
Purpose of the Study:
- To elucidate the anticancer mechanism of Chlorogenic acid (CA).
- To analyze CA's effect on gene expression in a mouse sarcoma model.
Main Methods:
- Whole mouse genome oligo microarray analysis in BALB/c mice with EMT-6 sarcoma.
- Treatment with varying doses of CA, docetaxel, interferon, and saline over 18 days.
- Time-series, Gene Ontology (GO), and pathway analyses followed by RT-qPCR validation of immune-related genes.
Main Results:
- CA significantly altered gene expression, with notable upregulation of immune-related genes (CaN, NFATC2, NFATC2ip, NFATC3).
- CA enhanced the expression of immune factors like IL-2R and IFN-γ.
- CA promoted the activation and proliferation of T cells, macrophages, and NK cells.
Conclusions:
- Chlorogenic acid (CA) bolsters antitumor immunity by enhancing immune cell surveillance and cytotoxic activity.
- CA's mechanism involves modulating specific immune-related gene expression, leading to suppressed tumor growth.

